Facebook
Twitterhttps://www.futuremarketinsights.com/privacy-policyhttps://www.futuremarketinsights.com/privacy-policy
The global sales of oxytocin are estimated to be worth USD 108.4 million in 2025 and are anticipated to reach a value of USD 245.7 million by 2035. Sales are projected to rise at a CAGR of 8.3% over the forecast period between 2025 and 2035. The revenue generated by oxytocin in 2024 was USD 99.2 million.
| Attributes | Key Insights |
|---|---|
| Historical Size, 2024 | USD 99.2 million |
| Estimated Size, 2025 | USD 108.4 million |
| Projected Size, 2035 | USD 245.7 million |
| Value-based CAGR (2025 to 2035) | 8.3% |
Semi Annual Market Update
| Particular | Value CAGR |
|---|---|
| H1 | 9.0% (2024 to 2034) |
| H2 | 8.7% (2024 to 2034) |
| H1 | 8.3% (2025 to 2035) |
| H2 | 7.8% (2025 to 2035) |
Country-wise Insights
| Countries | Value CAGR (2025 to 2035) |
|---|---|
| USA | 3.1% |
| Germany | 2.7% |
| UK | 6.3% |
| Spain | 4.5% |
| China | 9.2% |
| India | 9.9% |
Category-wise Insights
| Product Type | Postpartum |
|---|---|
| Value Share (2025) | 87.6% |
| By Distribution Channel | Hospital Pharmacies |
|---|---|
| Value Share (2025) | 64.5% |
Facebook
Twitterhttps://www.mordorintelligence.com/privacy-policyhttps://www.mordorintelligence.com/privacy-policy
The Oxytocin Market Report is Segmented by Indication (Antepartum, Postpartum), Route of Administration (Parenteral, Intranasal, Oromucosal), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America). The Market Forecasts are Provided in Terms of Value (USD).
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
The dataset contains the files (DARE_Workfile, Empathy_Workfile) used for the analyses of the study published by Fragkaki and Cima (2019) in Psychoneuroendocrinology. The study examined the effect of oxytocin administration on empathy and emotion recognition in 100 male adolescents living in residential youth care facilities. The study had a randomized, double-blind, placebo-controlled, within-subject design. The study included 3 sessions: screening session and two experimental sessions. In the experimental sessions, the participants received oxytocin in one session and placebo in the other session and performed the same experimental tasks on empathy and emotion recognition 30 min after administration. The order of the sprays as well as the order of the tasks were randomized using computer randomization. We performed mixed modeling to examined the effect of oxytocin on the outcome variables. The file “Documentation-ReadMe” describes the trial information, methodology, and the variables included in the datasets. The file "icu_dutch" is the Dutch version of the Inventory of callous-unemotional traits, the file ctq_dutch" is the Dutch version of the Childhood trauma questionnaire", and the file "ades_dutch" is the Dutch version of the Adolescent dissociative experiences scale.
Facebook
TwitterThis study examined oxytocin expression in experimental models of Alzheimer’s disease (AD), and evaluated the therapeutic potential of treatment with oxytocin. They investigated changes in oxytocin expression in APP/PS1 mouse model and developed a chronic intranasal treatment protocol to increase oxytocin levels in the brain. Then, tested oxytocin as a potential approach to attenuate microglial activation and reverse memory deficits. This dataset includes source data used to assemble different figures in the publication. The source data contains data about hypothalamic expression of oxytocin is reduced in AD models, chronic intranasal administration of oxytocin increases hippocampal oxytocin and attenuates fear response in mice, cellular and molecular impact of intranasal oxytocin in APP/PS1 mouse brains, oxytocin attenuates AβO-induced microglial activation in vitro, and intranasal oxytocin reverses social and non-social memory deficits in aged APP/PS1 mice.
Facebook
TwitterThe neurohormone oxytocin regulates many aspects of physiology primarily by binding to its receptor, the oxytocin receptor. The oxytocin receptor gene (Oxtr) has been shown to have alternative transcripts in the mouse brain which may each have different biological functions or be used in specific contexts. A popular animal model for studying oxytocin-dependent social behaviors is the prairie vole, a biparental and monogamous rodent. Alternative transcriptional capacity of Oxtr in prairie voles is unknown. We used 5′ rapid amplification of cDNA ends to identify alternative Oxtr transcription start sites in prairie vole brain tissue and uterine tissue. We then validated expression of specific transcripts in fetal brains and assessed the impact of exogenous oxytocin administration in utero on offspring brain development. We identified seven distinct Oxtr transcripts, all of which are present in both brain and uterine tissue. We then demonstrated that maternal oxytocin administration alters expression of a specific subset of Oxtr transcripts and that these different transcripts are under unique epigenetic regulation, such that in the perinatal period only one of the alternative transcripts is associated with DNA methylation in the Oxtr promoter. These data establish the existence of multiple Oxtr transcripts in prairie vole brain and uterine tissue and implicate oxytocin in the regulation of alternative transcript expression. These data have significant implications for our understanding of null mutant models in both mice and voles and translation in human birth and behavior.
Facebook
TwitterDetailed oxytocin protocol in each study.
Facebook
TwitterCC0 1.0 Universal Public Domain Dedicationhttps://creativecommons.org/publicdomain/zero/1.0/
License information was derived automatically
The implementation of an institutional oxytocin checklist did not affect expert assessment of the use of oxytocin in labor. Checklist is included within the publication's appendix.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Abstract: Affectionate touch, which is vital for mental and physical health, was restricted during the Covid-19 pandemic. This study investigated the association between momentary affectionate touch and subjective well-being, as well as salivary oxytocin and cortisol in everyday life during the pandemic. In the first step, we measured anxiety and depression symptoms, loneliness, and attitude toward social touch in a large cross-sectional online survey (N=1,050). From this sample, N=247 participants completed ecologically momentary assessments (EMA) over two days with six daily assessments by answering smartphone-based questions on affectionate touch and momentary mental state and providing concomitant saliva samples for cortisol and oxytocin assessment. Multilevel models showed that on a within-person level, affectionate touch was associated with decreased self-reported anxiety, general burden, stress, and increased oxytocin levels. On a between-person level, affectionate touch was associated with decreased cortisol levels and higher happiness. Moreover, individuals with a positive attitude towards social touch experiencing loneliness reported more mental health problems. Our results suggest that affectionate touch is linked to higher endogenous oxytocin in times of pandemic and lockdown and might buffer stress on a subjective and hormonal level. These findings might have implications for preventing mental burden during social contact restrictions.
Facebook
TwitterCC0 1.0 Universal Public Domain Dedicationhttps://creativecommons.org/publicdomain/zero/1.0/
License information was derived automatically
A collection of 5 brain maps. Each brain map is a 3D array of values representing properties of the brain at different locations.
Randomized, double-blind, placebo-controlled, cross-over design to compare the impacts of a single intranasal oxytocin dose on amygdala connectivity among individuals with schizophrenia (n = 22) versus healthy controls (n = 24).
Facebook
Twitterhttps://www.futuremarketinsights.com/privacy-policyhttps://www.futuremarketinsights.com/privacy-policy
The global oxytocin testing kits market is anticipated to reach USD 1,351.4 million by 2035, rising from USD 740.5 million in 2025 at a 6.2% CAGR.
| Attribute | Value |
|---|---|
| Market Size in 2025 | USD 740.5 million |
| Market Size in 2035 | USD 1,351.4 million |
| CAGR (2025 to 2035) | 6.2% |
Top Countries Manufacturing, Distributing, and Scaling Oxytocin Testing Kits
| Countries | CAGR (2025 to 2035) |
|---|---|
| United States | 5.2% |
| Germany | 5.8% |
| China | 8.9% |
| Japan | 4.4% |
| India | 10.3% |
Facebook
TwitterOxytocin is an endogenous neuropeptide hormone that influences social behaviour and bonding in mammals. Variations in oxytocin receptor (OXTR) expression may play a role in the social deficits seen in autism spectrum disorder. Previous studies from our laboratory found a dense population of OXTR in the human substantia nigra (SN), a basal ganglia structure in the midbrain that is important in both movement and reward pathways. Here, we explore whether differences in OXTR can be identified in the dopaminergic SN pars compacta of individuals with autism. Postmortem human brain tissue specimens were processed for OXTR receptor autoradiography from four groups: males with autism, females with autism, typically developing (TD) males and TD females. We found that females with autism had significantly lower levels of OXTR than the other groups. To examine potential gene expression differences, we performed in situ hybridization in adjacent slides to visualize and quantify OXTR mRNA as well as mRNA for tyrosine hydroxylase. We found no differences in mRNA levels for either gene across the four groups. These results suggest that a dysregulation in local OXTR protein translation or increased OXTR internalization/recycling may contribute to the differences in social symptoms seen in females with autism.This article is part of the theme issue ‘Interplays between oxytocin and other neuromodulators in shaping complex social behaviours’.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Demographic data, illness characteristics, basal and induced oxytocin levels and dimensions of empathy in patients with schizophrenia and healthy controls.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
This dataset accompanies the research article "Oxytocin signaling regulates maternally-directed behavior during early life". It includes Matlab data structures for each of the figures in the article. Within each structure are entries for each panel in the figure, including all data points presented in the panel. Panels that do not include any quantitative data (for example images) are also associated with entries in the matlab structures, but these entries are empty.
Facebook
TwitterCC0 1.0 Universal Public Domain Dedicationhttps://creativecommons.org/publicdomain/zero/1.0/
License information was derived automatically
FSL5.0
All 22 component maps included in: "Intranasal oxytocin enhances intrinsic corticostriatal functional connectivity in women." http://biorxiv.org/content/early/2016/08/09/068585
homo sapiens
fMRI-BOLD
rest eyes open
Other
Facebook
TwitterCC0 1.0 Universal Public Domain Dedicationhttps://creativecommons.org/publicdomain/zero/1.0/
License information was derived automatically
Main effect for healthy controls on oxytocin
Randomized, double-blind, placebo-controlled, cross-over design to compare the impacts of a single intranasal oxytocin dose on amygdala connectivity among individuals with schizophrenia (n = 22) versus healthy controls (n = 24).
homo sapiens
fMRI-BOLD
group
rest eyes closed
Z
Facebook
TwitterAttribution-NonCommercial-ShareAlike 4.0 (CC BY-NC-SA 4.0)https://creativecommons.org/licenses/by-nc-sa/4.0/
License information was derived automatically
The table contains 25 products whose active ingredient are classified under the same pharmacologic class Oxytocin [CS].
Facebook
TwitterIt has been demonstrated that secretion of several hormones can be classically conditioned, however, the underlying brain responses of such conditioning have never been investigated before. In this study we aimed to investigate how oxytocin administration and classically conditioned oxytocin influence brain responses. In total, 88 females were allocated to one of three groups: oxytocin administration, conditioned oxytocin, or placebo, and underwent an experiment consisting of three acquisition and three evocation days. Participants in the conditioned group received 24 IU of oxytocin together with a conditioned stimulus (CS) during three acquisition days and placebo with the CS on three evocation days. The oxytocin administration group received 24 IU of oxytocin and the placebo group received placebo during all days. On the last evocation day, fMRI scanning was performed for all participants during three tasks previously shown to be affected by oxytocin: presentation of emotional faces, crying baby sounds and heat pain. Region of interest analysis revealed that there was significantly lower activation in the right amygdala and in two clusters in the left superior temporal gyrus in the oxytocin administration group compared to the placebo group in response to observing fearful faces. The activation in the conditioned oxytocin group was in between the other two groups for these clusters but did not significantly differ from either group. No group differences were found in the other tasks. Preliminary evidence was found for brain activation of a conditioned oxytocin response; however, despite this trend in the expected direction, the conditioned group did not significantly differ from other groups. Future research should, therefore, investigate the optimal timing of conditioned endocrine responses and study whether the findings generalize to other hormones as well.
Facebook
TwitterBoth oxytocin (OT) and touch are key mediators of social attachment. In rodents, tactile stimulation elicits endogenous release of OT, potentially facilitating attachment and other forms of prosocial behavior, yet the relationship between endogenous OT and neural modulation remains unexplored in humans. Using serial sampling of plasma hormone levels during functional neuroimaging across two successive social interactions, we show that contextual circumstances of social touch influence not only current hormonal and brain responses but also later responses. Namely, touch from a male to his female romantic partner enhanced her subsequent OT release for touch from an unfamiliar stranger, yet females’ OT responses to partner touch were dampened following stranger touch. Hypothalamus and dorsal raphe activation reflected plasma OT changes during the initial social interaction. In the subsequent interaction, precuneus and parietal-temporal cortex pathways tracked time- and context-dependent va...
Facebook
TwitterPitocin is a prescription injectable medication containing oxytocin, used to induce or strengthen labor by stimulating uterine contractions. It is administered intravenously and manufactured by Endo USA, Inc. This information was generated using AI and is provided for informational and research purposes only.
Facebook
TwitterCC0 1.0 Universal Public Domain Dedicationhttps://creativecommons.org/publicdomain/zero/1.0/
License information was derived automatically
SPM{T_[416.0]} - contrast 3: Group x Drug: BDD greater in Oxyt
The present study assessed the effects of intranasal oxytocin on the neural basis of processing emotional faces in patients with body dysmorphic disorder (BDD). Twenty BDD patients and 22 matched healthy control participants participated in a randomized, double-blind placebo-controlled within-subject functional magnetic resonance imaging study. Following acute intranasal OXT (24 IU) or placebo administration, we examined group and OXT related differences in task-based amygdala activation and related functional connectivity in response to an emotional face-matching task of fearful, angry, disgusted, sad, surprised and happy faces.
homo sapiens
T
Facebook
Twitterhttps://www.futuremarketinsights.com/privacy-policyhttps://www.futuremarketinsights.com/privacy-policy
The global sales of oxytocin are estimated to be worth USD 108.4 million in 2025 and are anticipated to reach a value of USD 245.7 million by 2035. Sales are projected to rise at a CAGR of 8.3% over the forecast period between 2025 and 2035. The revenue generated by oxytocin in 2024 was USD 99.2 million.
| Attributes | Key Insights |
|---|---|
| Historical Size, 2024 | USD 99.2 million |
| Estimated Size, 2025 | USD 108.4 million |
| Projected Size, 2035 | USD 245.7 million |
| Value-based CAGR (2025 to 2035) | 8.3% |
Semi Annual Market Update
| Particular | Value CAGR |
|---|---|
| H1 | 9.0% (2024 to 2034) |
| H2 | 8.7% (2024 to 2034) |
| H1 | 8.3% (2025 to 2035) |
| H2 | 7.8% (2025 to 2035) |
Country-wise Insights
| Countries | Value CAGR (2025 to 2035) |
|---|---|
| USA | 3.1% |
| Germany | 2.7% |
| UK | 6.3% |
| Spain | 4.5% |
| China | 9.2% |
| India | 9.9% |
Category-wise Insights
| Product Type | Postpartum |
|---|---|
| Value Share (2025) | 87.6% |
| By Distribution Channel | Hospital Pharmacies |
|---|---|
| Value Share (2025) | 64.5% |